Skip to main content

CombiMatrix Takes $1.25M Milestone in Toppan Microarray Development Deal

NEW YORK, Dec. 2 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary has received a $1.25 million milestone payment from Toppan as part of a development agreement the companies entered in May.

The companies are co-developing a microarray product suite based on CombiMatrix's electrochemical detection technology. Upon commercialization, Toppan will manufacture microarrays for CombiMatrix or its partners and will share revenues and royalties from sales of the products.

CombiMatrix received an initial $1 million upfront payment from Toppan when the alliance was formed in May.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.